Movers and SHAKERS
Helius Medical Technologies (HSDT)(HSM:CA)
$32 Million Market Cap With A Multi-Billion TAM - What's The Disconnect?
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNSTM). For more information, visit www.heliusmedical.com.
Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Can't See the Forest For the Trees? We believe investors are missing the big picture at Helius Medical Technologies. Last week the Company received its second Breakthrough Designation from the U.S. Food and Drug Administration (FDA) for its PoNS device, this time for treatment of stroke patients with dynamic gait and balance deficits. Investors are missing the importance of the announcement, in our view.
Second Breakthrough Designation. To put last week's announcement in perspective, there are over 400 companies with a Breakthrough Device Designation. Only 5.65% have FDA clearance, which Helius is one of them. For a company to have a second BDD puts Helius in rare air ...
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.